CD8A and cancer: Our studies indicate that immunotherapy by super-charged NK cells in the presence of AJ2 oral supplementation may not only restore immune function in cancer patients by delaying or curtailing the growth potential of poorly-differentiated/stem-like pancreatic tumors, but also by expanding and activating CD8+ T cells.